title: Cholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice.
abstract: OBJECTIVE
  To determine whether plasma triglyceride levels in adult Glycosylphosphatidylinositol HDL-binding protein 1 (GPIHBP1)-deficient (Gpihbp1(-/-)) mice would be sensitive to cholesterol intake.
  
  
  RESULTS
  Gpihbp1(-/-) mice were fed a Western diet containing 0.15% cholesterol. After 4 to 8 weeks, their plasma triglyceride levels were 113 to 135 mmol/L. When 0.005% ezetimibe was added to the diet to block cholesterol absorption, Lpl expression in the liver was reduced significantly, and the plasma triglyceride levels were significantly higher (>170 mmol/L). We also assessed plasma triglyceride levels in Gpihbp1(-/-) mice fed Western diets containing either high (1.3%) or low (0.05%) amounts of cholesterol. The high-cholesterol diet significantly increased Lpl expression in the liver and lowered plasma triglyceride levels.
  
  
  CONCLUSIONS
  Treatment of Gpihbp1(-/-) mice with ezetimibe lowers Lpl expression in the liver and increases plasma triglyceride levels. A high-cholesterol diet had the opposite effects. Thus, cholesterol intake modulates plasma triglyceride levels in Gpihbp1(-/-) mice.
authors.affiliation: Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA.
authors.forename: Michael M
authors.initials: MM
authors.lastname: Weinstein
authors.forename: Yiping
authors.initials: Y
authors.lastname: Tu
authors.forename: Anne P
authors.initials: AP
authors.lastname: Beigneux
authors.forename: Brandon S J
authors.initials: BS
authors.lastname: Davies
authors.forename: Peter
authors.initials: P
authors.lastname: Gin
authors.forename: Constance
authors.initials: C
authors.lastname: Voss
authors.forename: Rosemary L
authors.initials: RL
authors.lastname: Walzem
authors.forename: Karen
authors.initials: K
authors.lastname: Reue
authors.forename: Peter
authors.initials: P
authors.lastname: Tontonoz
authors.forename: André
authors.initials: A
authors.lastname: Bensadoun
authors.forename: Loren G
authors.initials: LG
authors.lastname: Fong
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Young
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001384:Azetidines / Q000494:pharmacology*; D002784:Cholesterol / Q000378:metabolism*; D004041:Dietary Fats / Q000378:metabolism*; D004195:Disease Models, Animal; D000069438:Ezetimibe; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D018110:Receptors, Lipoprotein / Q000172:deficiency*; D014280:Triglycerides / Q000097:blood / Q000378:metabolism*
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D004041:Dietary Fats; C472779:GPI-HBP1 protein, mouse; D018110:Receptors, Lipoprotein; D014280:Triglycerides; D002784:Cholesterol; D000069438:Ezetimibe
references.citation: J Biol Chem. 2001 Sep 28;276(39):36083-90
references.pmid: 11432868
references.citation: Hepatology. 1995 Mar;21(3):863-74
references.pmid: 7875685
references.citation: Circ Cardiovasc Genet. 2010 Apr;3(2):169-78
references.pmid: 20124439
references.citation: Cell. 1984 Aug;38(1):275-85
references.pmid: 6088070
references.citation: Circ Res. 2008 Feb 1;102(2):250-6
references.pmid: 18032735
references.citation: J Biol Chem. 2002 May 24;277(21):18793-800
references.pmid: 11901146
references.citation: Biochim Biophys Acta. 2009 Jul;1791(7):679-83
references.pmid: 19272334
references.citation: Cell Metab. 2007 Apr;5(4):279-91
references.pmid: 17403372
references.citation: J Clin Invest. 1995 Dec;96(6):2555-68
references.pmid: 8675619
references.citation: J Lipid Res. 2005 Aug;46(8):1739-44
references.pmid: 15930515
references.citation: Mol Cell. 2001 Jan;7(1):161-71
references.pmid: 11172721
references.citation: J Biol Chem. 2001 Nov 16;276(46):43018-24
references.pmid: 11562371
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):956-62
references.pmid: 19304573
references.citation: J Biol Chem. 1989 May 15;264(14):7994-8003
references.pmid: 2722772
references.citation: J Lipid Res. 2010 Jun;51(6):1535-45
references.pmid: 20026666
references.citation: FEBS Lett. 1982 Oct 18;147(2):183-7
references.pmid: 7173389
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8132-7
references.pmid: 15928087
references.citation: Curr Opin Lipidol. 2007 Aug;18(4):389-96
references.pmid: 17620854
references.citation: Cell. 1997 May 2;89(3):331-40
references.pmid: 9150132
references.citation: Cell. 1998 May 29;93(5):693-704
references.pmid: 9630215
references.citation: Cell Metab. 2010 Jul 7;12(1):42-52
references.pmid: 20620994
references.citation: Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E271-88
references.pmid: 19318514
references.citation: Hepatology. 1985 Jul-Aug;5(4):683-92
references.pmid: 3926620
references.citation: J Biol Chem. 2004 Aug 6;279(32):33586-92
references.pmid: 15173162
references.citation: J Biol Chem. 2008 Dec 12;283(50):34511-8
references.pmid: 18845532
references.citation: Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2032-8
references.pmid: 11742881